1. UAE announces emergency approval for use of coronavirus vaccine  Al Jazeera English
  2. China coronavirus vaccine may be ready for public in November — official  INQUIRER.net
  3. Novavax Doubling Coronavirus Vaccine Production Capacity With Expanded India Deal  Motley Fool
  4. There Won't Be Enough COVID Vaccines for Everybody Until 2024, Warn Vaccine Makers  Futurism
  5. Novavax Expands Coronavirus Vaccine Capacity To More Than 2B Doses In 2021  Benzinga
  6. View Full coverage on Google News
Decision taken following a surge in infections over the weekend when the Gulf state registered 1,000 cases a day.Decision taken following a surge in infections over the weekend when the Gulf state registered 1,000 cases a day.

UAE announces emergency approval for use of coronavirus vaccine | Coronavirus pandemic News | Al Jazeera

The country has four Covid-19 vaccines in the final stage of clinical trials.The country has four Covid-19 vaccines in the final stage of clinical trials.

China coronavirus vaccine may be ready for public in November: official - World - DAWN.COM

Director of the Chinese Center for Disease Control and Prevention, Dr Gao Fu, said nationwide coronavirus vaccinations would only be necessary if there was another major outbreak.Director of the Chinese Center for Disease Control and Prevention, Dr Gao Fu, said nationwide coronavirus vaccinations would only be necessary if there was another major outbreak.

China will not carry out mass vaccinations on its population, Beijing's health chief says  | Daily Mail Online

Products often don't make it through Phase 3 trials. Covid-19 vaccines are no different.Products often don't make it through Phase 3 trials. Covid-19 vaccines are no different.

Opinion | Nobody wants vaccine trials to fail. But they just might. - The Washington Post

Gulf News Zero Campaign aims to raise awareness to help the country flatten the curveGulf News Zero Campaign aims to raise awareness to help the country flatten the curve

COVID-19: UAE vaccine strengthens fight against coronavirus | Editorials – Gulf News

Our View: Political operatives like Michael Caputo shouldn't be determining whether you can hear from some of the government's leading scientists.Our View: Political operatives like Michael Caputo shouldn't be determining whether you can hear from some of the government's leading scientists.

Our View: On COVID, politics infects science at CDC and FDA

Americans will need to take pandemic precautions well into 2021 — yes, even after a vaccine arrives.Americans will need to take pandemic precautions well into 2021 — yes, even after a vaccine arrives.

AstraZeneca Plc’s Covid-19 vaccine study remains paused in the U.S. pending a regulatory review of an incident in which a U.K. study participant became ill, federal officials said.AstraZeneca Plc’s Covid-19 vaccine study remains paused in the U.S. pending a regulatory review of an incident in which a U.K. study participant became ill, federal officials said.

AstraZeneca’s U.S. Trial Remains on Hold Pending Review by FDA - Bloomberg

The U.S. Food and Drug Administration said on Tuesday AstraZeneca Plc's COVID-19 vaccine trial in the United States is still on hold, and it was working with the company to figure out if there was a significant safety issue or not.The U.S. Food and Drug Administration said on Tuesday AstraZeneca Plc's COVID-19 vaccine trial in the United States is still on hold, and it was working with the company to figure out if there was a significant safety issue or not.

U.S. FDA investigating AstraZeneca's COVID-19 vaccine candidate | Reuters

The Korea Herald is South Korea’s largest English-language daily and the country’s sole member of the Asia News Network (ANN). The Korea Herald is South Korea’s largest English-language daily and the country’s sole member of the Asia News Network (ANN).

The Korea Herald

egypttoday,Politics,Business,Economy,Art,culture,Local news,Special interest,Press Review,News,ResourcesHead of the Russian Direct Investment Fund Kirill Dmitriev said Tuesday that Egypt is one of Russia’s main partners in the region.

Egypt to be gate for "Sputnik V" vaccine to Africa: Russian official - Egypt Today

Page UnavailablePage Unavailable

Page Unavailable - ABC News

Science News: NEW YORK: Independent scientists and public health experts are criticising vaccine companies for a lack of public transparency, particularly their ref.Science News: NEW YORK: Independent scientists and public health experts are criticising vaccine companies for a lack of public transparency, particularly their ref.

Scientists alarmed by vaccine makers’ ‘secrecy’ about trials - Times of India

Science News: NEW YORK: Independent scientists and public health experts are criticising vaccine companies for a lack of public transparency, particularly their ref.Times of India brings the Latest & Top Breaking News on Politics and Current Affairs in India & around the World, Cricket, Sports, Business, Bollywood News and Entertainment, Science, Technology, Health & Fitness news & opinions from leading columnists.

Scientists alarmed by vaccine makers’ ‘secrecy’ about trials - Times of India

COVID-19 vaccines being developed in China might be available for use by the general public as early as November, according to a top scientist with the Chinese Center...COVID-19 vaccines being developed in China might be available for use by the general public as early as November, according to a top scientist with the Chinese Center...

COVID-19 Vaccine Likely Available for Public Use in November, Top Chinese Scientist Says - Sputnik International

Trials of AstraZeneca Covid-19 vaccine remain on hold until midweekTrials of AstraZeneca Covid-19 vaccine remain on hold until midweek

Coronavirus: Global infections approach 30 million

The studies were paused for less than a week.The studies were paused for less than a week.

AstraZeneca Resumes U.K. Clinical Trials of Its Coronavirus Vaccine After a Safety Pause | The Motley Fool

50 countries have already expressed interest in purchasing the Sputnik V vaccine, developed by Russia’s Gamaleya Research Institute. The Russian Direct Investment Fund...50 countries have already expressed interest in purchasing the Sputnik V vaccine, developed by Russia’s Gamaleya Research Institute. The Russian Direct Investment Fund...

Russian Direct Investment Fund CEO Stresses Tech Based on Monkey Adenoviral Vectors 'Yet Unproven' - Sputnik International

Some volunteers have quit Johnson & Johnson's COVID-19 vaccine trial in Spain after news of side effects in a participant in AstraZeneca's trial, the Spanish programme's lead investigator told Reuters on Tuesday.Some volunteers have quit Johnson & Johnson's COVID-19 vaccine trial in Spain after news of side effects in a participant in AstraZeneca's trial, the Spanish programme's lead investigator told Reuters on Tuesday.

Some volunteers quit J&J COVID-19 trial in Spain after AstraZeneca scare: investigator | Article [AMP] | Reuters

German biotech firm BioNTech said on Tuesday it had secured almost $450 million in government funding to speed up work on its COVID-19 vaccine candidate and expand its production capacity in Germany. BioNTech and partners Pfizer Inc and China's Shanghai Fosun Pharmaceutical Group Co Ltd are amongGerman biotech firm BioNTech said on Tuesday it had secured almost $450 million in government funding to speed up work on its COVID-19 vaccine candidate and expand its production capacity in Germany. BioNTech and partners Pfizer Inc and China's Shanghai Fosun Pharmaceutical Group Co Ltd are among

BioNTech wins $445 million German grant for COVID-19 vaccine

British scientists are beginning a small study comparing how two experimental coronavirus vaccines might work when they are inhaled by people instead of being injected.British scientists are beginning a small study comparing how two experimental coronavirus vaccines might work when they are inhaled by people instead of being injected.

A group of scientists sent a formal letter to the Lancet on Monday outlining doubts about the accuracy of early data on Russia's COVID-19 vaccine, one of the authors said, adding further fuel to a dispute surrounding the "Sputnik-V" shot.A group of scientists sent a formal letter to the Lancet on Monday outlining doubts about the accuracy of early data on Russia's COVID-19 vaccine, one of the authors said, adding further fuel to a dispute surrounding the "Sputnik-V" shot.

Fifteen scientists launch critique of Russia’s COVID-19 vaccine data – EURACTIV.com

The Oxford and Imperial vaccines are both being tested in trials through intramuscular injection, but scientists from Imperial said that vaccines delivered via inhalation could potentially deliver a more specialised response.The Oxford and Imperial vaccines are both being tested in trials through intramuscular injection, but scientists from Imperial said that vaccines delivered via inhalation could potentially deliver a more specialised response.

Researchers trial inhaled versions of Oxford and Imperial Covid-19 vaccine candidates - world news - Hindustan Times

Recon: AstraZeneca resumes COVID vaccine trials in South Africa, Brazil, US study still on hold | RAPS

As temperatures drop, doctors expect new coronavirus cases to rise, perhaps doubling the number of US deaths by January.As temperatures drop, doctors expect new coronavirus cases to rise, perhaps doubling the number of US deaths by January.

Coronavirus pandemic expected to get worse before it gets better, experts say - CNET

Emergency use of the vaccine is fully and completely compatible with the regulations and laws that allow a faster review of licensing procedures - ZAWYA MENA EditionEmergency use of the vaccine is fully and completely compatible with the regulations and laws that allow a faster review of licensing procedures

Germany boosts own vaccine makers in race for COVID-19 jabGermany boosts own vaccine makers in race for COVID-19 jab

Germany boosts own vaccine makers in race for COVID-19 jab | Taiwan News

About one in seven volunteers who received a groundbreaking Russian coronavirus vaccine have complained of side effects such as muscle pain, weakness, and fever, according to the country's Minister for Health Mikhail Murashko.About one in seven volunteers who received a groundbreaking Russian coronavirus vaccine have complained of side effects such as muscle pain, weakness, and fever, according to the country's Minister for Health Mikhail Murashko.

14% of volunteers testing pioneering Russian Covid-19 vaccine ‘Sputnik V’ have experienced side effects, health ministry says — RT Russia & Former Soviet Union

Experts say direct delivery to the lungs may give a better immune response.Experts say direct delivery to the lungs may give a better immune response.

Coronavirus: UK to test inhaled vaccines - BBC News

The United Arab Emirates has become the first country outside China to approve emergency usage of a Chinese Covid-19 vaccine candidate, in a vote of confidence for a state-backed drugmaker racing global rivals to stop the spread of the coronavirus.The United Arab Emirates has become the first country outside China to approve emergency usage of a Chinese Covid-19 vaccine candidate, in a vote of confidence for a state-backed drugmaker racing global rivals to stop the spread of the coronavirus.

In Global Covid-19 Vaccine Race, Chinese Shot Receives First Foreign Approval - WSJ

The biggest drugmakers in the hunt for a COVID-19 vaccine have been racing to lock up national supply deals for months in anticipation of global demand for a winner. Even the lesser-known contestants are selling their wares around the world, though—and the U.K. appears to be buying. The biggest drugmakers in the hunt for a COVID-19 vaccine have been racing to lock up national supply deals for months in anticipation of global demand for a winner. Even the lesser-known contestants are selling their wares around the world, though—and the U.K. appears to be buying. 

Valneva signs $1.6B supply, development agreement with U.K. for coronavirus vaccine hopeful | FiercePharma

SEOUL • South Korea has said it plans to spend 172 billion won (S$198 million) to procure coronavirus vaccines, initially aiming to secure a supply for 30 million people, or 60 per cent of its population, as it battles persistent outbreaks of new cases.. Read more at straitstimes.com.East Asia News -SEOUL • South Korea has said it plans to spend 172 billion won (S$198 million) to procure coronavirus vaccines, initially aiming to secure a supply for 30 million people, or 60 per

South Korea to spend $198m to procure Covid-19 vaccines for 60% of population, East Asia News & Top Stories - The Straits Times

Over 300 volunteers have been inoculated during the post-registration trials of Russia's COVID-19 vaccine, dubbed Sputnik V, around 14 percent of them have reported fatigue, muscle pain or high body temperature, Russian Health Minister Mikhail Murashko said on Tuesday. "Over 300 persons have been vaccinated.

Over 300 Volunteers Get Russian COVID-19 Vaccine - Novinite.com - Sofia News Agency

AstraZeneca Plc’s Covid-19 vaccine trial remains on hold in the U.S. as regulators examine a serious side effect suffered by a U.K. patient, Reuters reported on Monday.

AstraZeneca trial on hold pending U.S. scrutiny, Reuters reports - BNN Bloomberg

UK trials of the Oxford and AstraZeneca vaccine have resumed after a brief pause, yet key details of the events involved have not been released. UK trials of the Oxford and AstraZeneca vaccine have resumed after a brief pause, yet key details of the events involved have not been released.UK trials of the Oxford and AstraZeneca vaccine have resumed after a brief pause, yet key details of the events involved have not been released.

Scientists relieved as coronavirus vaccine trial restarts — but question lack of transparency

UK trials of the Oxford and AstraZeneca vaccine have resumed after a brief pause, yet key details of the events have not been releasedUK trials of the Oxford and AstraZeneca vaccine have resumed after a brief pause, yet key details of the events have not been released

Coronavirus Vaccine U.K. Trial Restarts, But Scientists Question Lack of Transparency - Scientific American

China's COVID-19 vaccine could be ready for public in November: expert - CGTN

In March, about 180 immunologists and epidemiologists with China National Pharmaceutical Industry Corp (SinoPharm), together with their families, signedIn March, about 180 immunologists and epidemiologists with China National Pharmaceutical Industry Corp (SinoPharm), together with their families, signed up to be the first volunteers to receive jab…

Debate rages over China's Covid-19 vaccines - Asia Times

The director of the Chinese CDC, Gao Fu, reportedly said that not everyone in the country will need to get vaccinated against COVID-19.The director of the Chinese CDC, Gao Fu, reportedly said that not everyone in the country will need to get vaccinated against COVID-19.

COVID-19: China prioritises frontline workers, says no need to vaccinate entire population - Republic World

404 Not Found

The United Arab Emirates (UAE) on Monday granted emergency approval for use of a coronavirus vaccine developed in China, six weeks after human trials on the vaccine started in the country.

UAE approves urgent use of China-developed COVID-19 vaccine after test on 31,000 volunteers - Global Times

'It will be very soon. The progress is currently very smooth,' said a Chinese official.'It will be very soon. The progress is currently very smooth,' said a Chinese official.

Coronavirus vaccine in China could be ready by November say officials - Business Insider

At a time when the whole world is eagerly awaiting good news to fight the Coronavirus, Serum Institute of India CEO Adar Poonawalla expressed doubt thatAt a time when the whole world is eagerly awaiting good news to fight the Coronavirus, Serum Institute of India CEO Adar Poonawalla expressed doubt that

Vaccine Might Not Be Available To All Till 2024: Serum Institute CEO - Gulte